|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 8280 WILLOW OAKS CORPORATE DRIVE |
Address2 | SUITE 500 |
City | FAIRFAX |
State | VA |
Zip Code | 22031 |
Country | USA |
3. Principal place of business (if different than line 2)
City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 57737-12
|
||||||||
|
6. House ID# 352510000
|
TYPE OF REPORT | 8. Year | 2011 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Dave Adler, Director of Government Relations |
Date | 10/18/2011 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HOM
16. Specific lobbying issues
To protect access to medical isotopes used in cancer treatments such as brachytherapy and sterotactic radiosurgery.
Development of domestic isotope production, specifically the American Medical Isotope Production Act of 2011 (S. 99).
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Energy - Dept of
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Dave |
Adler |
|
|
|
Jennifer |
Knowles |
|
|
|
Cynthia |
Tomlinson |
|
|
|
Shandi |
Hill |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Support a definition for meaningful use of health care technology that allows specialty physicians to benefit from incentive payments for the use of specialty-specific products.
Support for national reporting database of medical errors related to the delivery of radiation therapy.
Support efforts to raise awareness of nuclear safety culture issues and to improve safety in the medical use of radioactive materials and in all aspects of radiation use.
Support for the development of an appropriate medical event definition.
Support to ensure that patient care advances in biomedical research impacting patient care are not compromised by any policies imposed on the medical use and research applications of cesium chloride.
Support modifications to the FDA review process of medical devices to consider interoperability issues.
Support for implementation of patient protection and insurance expansions from the Patient Protection and Affordable Care Act (PL No: 111-148).
Support for setting conditions for lawsuits arising from health care liability claims, specifically the Help Efficient, Accessible, Low-cost, Timely Healthcare (HEALTH) Act of 2011 (H.R. 5).
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Energy - Dept of, Executive Office of the President (EOP), Food & Drug Administration (FDA), Nuclear Regulatory Commission (NRC)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Dave |
Adler |
|
|
|
Jennifer |
Knowles |
|
|
|
Cynthia |
Tomlinson |
|
|
|
Shandi |
Hill |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Support for legislation to rebase the Medicare physician payment formula to stabilize physician payments.
Support for legislation to insure patient safety and preserve the integrity of the Medicare program by ending abuses of the physician self-referral law for radiation therapy services.
Support for structural changes that lead to delivering high-quality care for patients while increasing efficiencies and promoting Medicare sustainability; oppose radiation oncology benefit managers.
Support for Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act (HR 2104).
Support for repealing the establishment of an Independent Payment Advisory Board that would develop and submit detailed proposals to reduce the per capita rate of growth in Medicare spending, specifically the Medicare Decisions Accountability Act of 2011 (H.R. 452).
Support for ensuring radiation oncologists participation in the Medicare electronic health record incentive program.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Government Accountability Office (GAO), Medicare Payment Advisory Commission (MedPAC)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Dave |
Adler |
|
|
|
Jennifer |
Knowles |
|
|
|
Cynthia |
Tomlinson |
|
|
|
Shandi |
Hill |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Support legislation to increase the budget for the National Institutes of Health and the Centers for Disease Control and Prevention for fiscal year 2011 and 2012.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Dave |
Adler |
|
|
|
Jennifer |
Knowles |
|
|
|
Cynthia |
Tomlinson |
|
|
|
Shandi |
Hill |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
Support for lifting the salary cap on medical physicists at Veterans Affairs radiation oncology service centers.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Veterans Affairs - Dept of (VA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Dave |
Adler |
|
|
|
Jennifer |
Knowles |
|
|
|
Cynthia |
Tomlinson |
|
|
|
Shandi |
Hill |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |